Progress made on a 'bionic pancreas' for diabetics
By MARILYNN MARCHIONE - AP - Sun Jun 15, 8:22PM CDT
Scientists have made big progress on a "bionic pancreas" to free some people with diabetes from the daily ordeal of managing their disease. A wearable, experimental device passed a real-world test, constantly monitoring blood sugar and automatically giving insulin or a sugar-boosting drug as needed, doctors said Sunday.
Better Stock Today: InvenSense vs. Johnson & Johnson
Max Macaluso and David Williamson, The Motley Fool - Motley Fool - Sun Jun 15, 11:00AM CDT
In the spirit of World Cup competition, we're holding our own tournament in search of the Better Stock Today. We're pitting 32 companies against each other, and you, the reader, will determine the winner. InvenSense takes on Johnson &...
GI Go Fund and Johnson & Johnson Host Military Career Workshop for Dozens of Veterans in San Diego, CA
PRWeb - Sun Jun 15, 4:01AM CDT
For the past two years, the GI Go Fund has worked together with Johnson & Johnson to create a unique career workshop concept, where veterans and military supporters who were employed at the pharmaceutical giant and other Fortune 100 companies would work with unemployed veterans to develop their resumes and improve their overall employment skills in a one-on-one atmosphere at their corporate headquarters. The partnership led to multiple Military Career Workshops hosted in the New York/New Jersey region, with over 400 veterans getting the help they needed to improve their hiring prospects.
3 Dividend Stocks Fighting for Growth
Todd Campbell, The Motley Fool - Motley Fool - Sat Jun 14, 2:07PM CDT
The holy grail of drug development is blockbuster status, the unofficial stamp of commercial success awarded to therapies when their sales eclipse $1 billion annually. Developing blockbuster drugs, however, is anything but easy. It costs hundreds...
3 Reasons Johnson & Johnson Is a Great Dividend Stock for New Investors
Michael Douglass and David Williamson, The Motley Fool - Motley Fool - Fri Jun 13, 10:14PM CDT
Johnson & Johnson is a great stock for a new investor (particularly a new health care investor). It's large . In fact, it's the largest pharma and medical tech company in the world. It's diverse . The consumer and medical device segments...
Final Glance: Pharmaceuticals companies
AP - Fri Jun 13, 5:04PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Final Glance: Medical Devices companies
AP - Fri Jun 13, 5:04PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
J&J, ViiV Healthcare Tie Up for Single-Tablet HIV Treatment - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 3:20PM CDT
ViiV Healthcare has entered into an agreement with Janssen R&D Ireland Ltd., a subsidiary of Johnson & Johnson.
Why You Should Invest in a U.S. World Cup Run
at The Street - Fri Jun 13, 1:00PM CDT
U.S. Soccer is a long-term investment, but its head coach believes the payoff will be big. Corporate sponsors and broadcasters are in. Why aren't you?
Using Investors' Emotions to Time the Stock Market? Yes, You Can
at The Street - Fri Jun 13, 12:58PM CDT
It's ignorant to think no measure of market timing is necessary to successfully manage money.
Midday Glance: Medical Devices companies
AP - Fri Jun 13, 12:23PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
Midday Glance: Pharmaceuticals companies
AP - Fri Jun 13, 12:23PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Shares of JNJ Up 13.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jun 13, 11:16AM CDT
SmarTrend identified an Uptrend for Johnson & Johnson (NYSE:JNJ) on February 10th, 2014 at $90.44. In approximately 4 months, Johnson & Johnson has returned 13.40% as of today's recent price of $102.56.
Early Glance: Pharmaceuticals companies
AP - Fri Jun 13, 9:31AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Early Glance: Medical Devices companies
AP - Fri Jun 13, 9:31AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Health Care Sector Equities Coverage -- Research on Johnson and Johnson, Medicines Co., Merck, and Novo Nordisk
PR Newswire - Fri Jun 13, 6:40AM CDT
The US markets on Thursday, June 12, 2014 ended on a negative note as the Dow Jones Industrial Average finished at 16,734.19, down 0.65% and the NASDAQ Composite closed at 4,297.63, down 0.79%. The S&P 500 finished the session 0.71% lower at 1,930.11. During the trading session, eight out of ten sectors finished on a lower note. The S&P 500 Health Care Sector Index ended the day at 688.58, down 0.56%, whereas the index has advanced 1.97% in the last one month. Investor-Edge has initiated coverage on the following equities: Johnson & Johnson (NYSE: JNJ), The Medicines Co. (NASDAQ: MDCO), Merck & Co. Inc. (NYSE: MRK) and Novo Nordisk (NYSE: NVO). Free technical research on JNJ, MDCO, MRK and NVO can be downloaded upon signing up at:
Approvals, Agreements, Name Change, and Partnerships - Analyst Notes on Johnson & Johnson, Furiex Pharmaceuticals, Select Medical, CTI and Hill-Rom
PR Newswire - Fri Jun 13, 5:00AM CDT
Today, Analysts Review released its analysts' notes regarding Johnson & Johnson (NYSE: JNJ), Furiex Pharmaceuticals, Inc. (NASDAQ: FURX), Select Medical Holdings Corporation (NYSE: SEM), CTI BioPharma Corp. (NASDAQ: CTIC) and Hill-Rom Holdings, Inc. (NYSE: HRC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3701-100free.
Corporate Action Network and Injured Women Call on Illinois Attorney General to Investigate Johnson & Johnson
Business Wire - Thu Jun 12, 5:25PM CDT
Corporate Action Network and Illinois women who have been seriously injured by pelvic mesh implants asked Illinois Attorney General Lisa Madigan to investigate Johnson & Johnson (JNJ) for its dangerous pelvic mesh implants, citing their personal health problems and costs incurred by Illinois taxpayers.